Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Circulating DNA, Circulating RNA, Circulating Tumor Cells

Tony Godfrey's Biography



Tony Godfrey, Associate Chair – Research, Department of Surgery, Boston University Medical Center

Tony E. Godfrey, PhD, Associate Chair for Surgical Research and Associate Professor of Surgery, Boston University School of Medicine, earned a bachelor’s of science degree in biochemistry from Brunel University in England, followed by a doctorate in molecular biology and biochemistry, also from Brunel. He attended the University of California, San Francisco, for postdoctoral fellowships followed by faculty appointments at the University of Pittsburgh, Mount Sinai Hospital, NY, and the University of Rochester Medical Center in Rochester, NY. Dr. Godfrey’s research is focused on cancer genetics and molecular pathology. Research projects use state-of-the-art genetic and genomic approaches to address clinical needs in the areas of cancer diagnosis, prognosis and therapy. Currently the major focus of Dr. Godfrey’s research is on Barrett’s esophagus and esophageal adenocarcinoma. The Godfrey lab works closely with translational research teams comprised of surgeons, pathologists and oncologists in order to develop new molecular approaches to cancer detection, staging and treatment.

Tony Godfrey Image

Detection of Circulating, Cell Free DNA in Plasma from Esophageal Adenocarcinoma Patients Using Digital PCR and NGS

Tuesday, 24 March 2015 at 08:30

Add to Calendar ▼2015-03-24 08:30:002015-03-24 09:30:00Europe/LondonDetection of Circulating, Cell Free DNA in Plasma from Esophageal Adenocarcinoma Patients Using Digital PCR and NGSSELECTBIOenquiries@selectbiosciences.com

Detection and quantification of mutated, circulating tumor DNA in plasma or serum of cancer patients has great potential as a biomarker for cancer detection, treatment selection and measuring response to therapy. We are using digital PCR and ultra-sensitive NGS to evaluate circulating tumor DNA  for monitoring response to neoadjuvant therapy in patients with oesophageal adenocarcinoma. This talk will focus on technical challenges faced and how they are being overcome.


Add to Calendar ▼2015-03-23 00:00:002015-03-24 00:00:00Europe/LondonCirculating DNA, Circulating RNA, Circulating Tumor CellsSELECTBIOenquiries@selectbiosciences.com